Skip to main content
NIH Record - National Institutes of Health

Full-Dose Blood Thinners Improve Outcomes in Hospitalized Covid Patients

In large clinical trials, full-dose anticoagulation (blood thinner) treatments given to moderately ill patients hospitalized for Covid-19 reduced the need for vital organ support, such as ventilation. A trend in reduced mortality was also observed and is under further study. With large numbers of Covid-19 patients requiring hospitalization, these outcomes could also help reduce the overload on intensive care units around the world.


Back to Top